Phase II study of Hyper-CVAD with pegylated liposomal doxorubicin alternating with methotrexate and cytarabine (HCVIDD/MA) in patients with newly diagnosed T- and NK-cell lymphoma (T/NKCL) Meeting Abstract
| Authors: | Chihara, D.; Pro, B.; Loghavi, S.; Miranda, R. N.; Medeiros, L. J.; Fanale, M. A.; Hagemeister, F. B.; Fayad, L.; Romaguera, J. E.; Samaniego, F.; Neelapu, S. S.; Younes, A.; Fowler, N. H.; Rodriguez, M. A.; Wang, M.; Kwak, L. W.; McLaughlin, P.; Dang, N. H.; Oki, Y. |
| Abstract Title: | Phase II study of Hyper-CVAD with pegylated liposomal doxorubicin alternating with methotrexate and cytarabine (HCVIDD/MA) in patients with newly diagnosed T- and NK-cell lymphoma (T/NKCL) |
| Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036901850 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.15_suppl.8538 |
| Notes: | Meeting Abstract: 8538 -- Source: Wos |
